Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


1010 Hanhwa Bizmetro 1st, 242 Digital-ro, Guro-gu
South Korea

NGeneBio Co., Ltd. was founded in October 2015, develops next generation sequencing (NGS)-based in vitro diagnostics (IVD)/companion diagnostics (CDx) products and clinical bioinformatics software (SW). 
The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTest) with clinical analysis SW (NGeneAnalySys) and received CE-IVD mark in Jun/2017, followed by KFDA approval in Dec/2017 based on clinical trial with over 200 BRCA clinical samples.
NGS panels for solid tumor (SOLIDaccuTest)/hematologic malignancies (HEMEaccuTest) have been launched, inclusive of clinical data analysis and report generation SW platform. In support of oncology clinical lab community, our mission is to provide clinically validated NGS-IVD/CDx products/services with the convergence of innovative biotechnology and bioinformatics.
The company launched short tandem repeat (STR) kit for genetic profiling (forensic & paternity test), IDaccuTest, compatible with Sanger sequencers.

Exhibited At: 

Clinical NGS Data Analysis Software - NGeneAnalySys

Forensic, Paternity Test DNA Profiling - IDaccuTest™

Hematologic Malignancy NGS kit HEMEaccuTest™

Solid Tumor NGS Kit - SOLIDaccuTest™

Breast Cancer Kit - BRCAaccuTest™